Company Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Biotechnology & Medical Research

Real-time Euronext Bruxelles 12:35:25 2024-03-28 pm EDT 5-day change 1st Jan Change
1.505 EUR -3.53% Intraday chart for Sequana Medical N.V. +3.08% -62.38%

Business Summary

Sequana Medical N.V. is a commercial stage medical device company utilizing its proprietary alfapump® and DSR® (Direct Sodium Removal) technologies to develop innovative treatments for fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump is a fully-implanted, wireless device that automatically pumps fluid from the abdomen into the bladder, where it is removed naturally through urination. The alfapump is CE-marked for the management of refractory ascites due to liver cirrhosis and malignant ascites and has been granted breakthrough device designation by the US FDA with a North American pivotal study underway. DSR is a novel approach to manage sodium and fluid overload through use of a sodium-free infusate administered into the abdominal cavity. The alfapump DSR® combines DSR therapy with the proven alfapump platform and is in clinical development as potential treatment for decompensated heart failure patients.

Number of employees: 70

Sales per Business

EUR in Million2021Weight2022Weight Delta
Medical Device
100.0 %
0 100.0 % 1 100.0 % +149.04%

Sales per region

EUR in Million2021Weight2022Weight Delta
Germany
75.1 %
0 85.0 % 1 75.1 % +119.89%
France
12.4 %
0 10.3 % 0 12.4 % +200.99%
Switzerland
9.3 %
0 4.7 % 0 9.3 % +389.50%
Rest of the World
3.3 %
0 0.0 % 0 3.3 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 56 15-12-31
Director of Finance/CFO 50 -
Chief Tech/Sci/R&D Officer 56 -
Chief Tech/Sci/R&D Officer 60 20-05-03
Investor Relations Contact - 18-06-30
General Counsel 42 19-04-30
Corporate Officer/Principal 50 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 22-07-18
Director/Board Member 68 18-11-07
Director/Board Member - Nov. 09
Director/Board Member 63 -
Chief Executive Officer 56 15-12-31
Chairman 61 18-11-07
Director/Board Member 60 21-08-31
Director/Board Member 60 22-08-24
Director/Board Member - 23-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 30,243,542 23,154,610 ( 76.56 %) 0 76.56 %

Shareholders

NameEquities%Valuation
Neomed Management AS
15.19 %
4,288,988 15.19 % 11 M €
SFPI-FPIM SA/NV
9.705 %
2,740,854 9.705 % 7 M €
LSP Management Group BV
6.685 %
1,887,895 6.685 % 5 M €
Participatiemaatschappij Vlaanderen NV
5.866 %
1,656,803 5.866 % 4 M €
Newton Biocapital Partners SRL
3.904 %
1,102,529 3.904 % 3 M €
Grac SS
3.570 %
1,008,333 3.570 % 3 M €
Sensinnovat BV
3.189 %
900,769 3.189 % 2 M €
LSP Advisory BV
1.318 %
372,099 1.318 % 962 375 €
CAPFI DELEN Asset Management NV
0.2957 %
83,500 0.2957 % 215 959 €

Company contact information

Sequana Medical NV

Kortrijksesteenweg 1112 Sint-Denijs-Westrem

9051, Ghent

+32 9 298 28 28

http://www.sequanamedical.com
address Sequana Medical N.V.(SEQUA)